Atara Biotherapeutics Inc.
ATRA | NASDAQ
$8.01
-$0.52 (-6.10%)
At close: Oct 30, 2026, 4:00 PM ET
$8.01
$0.00 (0.00%)
Pre-market:
Nov 2, 2026, 8:54 AM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 6.19M | 23.14M | 120.77M | 151.93M | 188.67M | 199.73M | 128.94M | 100.44M | 62.39M | 34.7M | 8.57M | 4.54M | 6.86M | 57.49M | 63.57M | 70.9M | 71.81M | 24.1M | 20.34M | 12.79M | 7.42M | 3.55M |
Cost of Revenue | 534K | 897K | 21.21M | 27.9M | 35.39M | 39.46M | 21.01M | 17.37M | 12.39M | 10.66M | 8.89M | 65.7M | 63.08M | 60.19M | 134.93M | 154.1M | 154.1M | 222.57M | 211.67M | 135.07M | 194.95M | 188.03M |
Gross Profit | 5.66M | 22.24M | 99.56M | 124.03M | 153.28M | 160.27M | 107.93M | 83.07M | 50M | 24.05M | -313K | -61.16M | -56.22M | -2.7M | -71.36M | -83.2M | -82.29M | -198.47M | -191.33M | -122.28M | -187.52M | -184.48M |
Operating Income | -14.23M | -6.31M | 35.86M | 26.22M | 8.04M | -13.39M | -83.44M | -124.51M | -172.37M | -225.55M | -269.32M | -291.58M | -306.59M | -267.31M | -280.51M | -298.38M | -298.57M | -350.44M | -340.46M | -328.76M | -318.65M | -312.6M |
Interest Income | 436K | 501K | 683K | 1.18M | 1.44M | 1.74M | 2.11M | 2.22M | 2.98M | 4.23M | 5.43M | 4.72M | 4.47M | 3.48M | 1.91M | 1.99M | 1.16M | 685K | 457K | 771K | 987K | 1.26M |
Pretax Income | -16.66M | -9.44M | 32.72M | 23.41M | 5.76M | -15.68M | -85.42M | -133.14M | -181.03M | -233.09M | -276.11M | -290.24M | -304.51M | -214.93M | -228.29M | -247.04M | -247.62M | -349.87M | -340.1M | -328.08M | -317.75M | -311.43M |
Net Income | -16.69M | -9.47M | 32.69M | 23.4M | 5.8M | -15.64M | -85.4M | -133.16M | -181.05M | -233.11M | -276.13M | -290.25M | -304.54M | -214.97M | -228.3M | -247.08M | -247.65M | -349.91M | -340.14M | -328.1M | -317.78M | -311.45M |
Selling & General & Admin | 15.68M | 17.8M | 25.67M | 30.84M | 37.27M | 40.25M | 39.89M | 40.83M | 42.66M | 47.08M | 49.84M | 49.28M | 55.96M | 61.43M | 68.13M | 80.13M | 81.05M | 81.63M | 78.8M | 70.59M | 65.57M | 62.57M |
Research & Development | 4.21M | 10.18M | 37.45M | 66.39M | 107.39M | 133.41M | 151.48M | 166.74M | 179.71M | 202.52M | 219.17M | 237.7M | 250.97M | 259.73M | 272.53M | 289.15M | 289.33M | 292.91M | 282M | 268.42M | 257.97M | 251.05M |
Other Expenses | n/a | 579K | 579K | 579K | 579K | n/a | n/a | n/a | n/a | n/a | n/a | -56.55M | -56.55M | -56.55M | -131.51M | -154.1M | -154.1M | -222.57M | -211.67M | -132.53M | -192.41M | -185.5M |
Operating Expenses | 19.89M | 28.55M | 63.7M | 97.81M | 145.24M | 173.66M | 191.37M | 207.58M | 222.37M | 249.6M | 269.01M | 230.43M | 250.37M | 264.61M | 209.15M | 215.18M | 216.28M | 151.97M | 149.13M | 206.48M | 131.13M | 128.12M |
Interest Expense | 2.82M | 3.61M | 3.79M | 3.92M | 4.19M | 4.48M | 4.62M | 4.77M | 4.99M | 5.1M | 5.29M | 4.11M | 2.84M | 1.59M | 256K | 256K | 133K | 4K | 90K | 90K | 90K | 90K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 20.42M | 29.45M | 84.91M | 125.71M | 180.63M | 213.12M | 212.38M | 224.95M | 234.75M | 260.25M | 277.89M | 296.13M | 313.46M | 324.8M | 344.09M | 369.28M | 370.38M | 374.54M | 360.8M | 341.55M | 326.07M | 316.15M |
Income Tax Expense | 29K | 31K | 31K | 12K | -33K | -36K | -12K | 18K | 16K | 17K | 15K | 6K | 35K | 34K | 12K | 40K | 30K | 46K | 46K | 24K | 30K | 15K |
Shares Outstanding (Basic) | 15.03M | 14.08M | 12.54M | 13.56M | 12.2M | 10.76M | 10.69M | 7.47M | 6.14M | 5.62M | 4.33M | 4.26M | 4.2M | 4.16M | 4.13M | 4.1M | 4.07M | 4.03M | 3.9M | 3.74M | 3.68M | 3.66M |
Shares Outstanding (Diluted) | 15.03M | 14.08M | 12.72M | 13.56M | 12.31M | 10.85M | 10.69M | 7.47M | 6.14M | 5.62M | 4.33M | 4.26M | 4.2M | 4.16M | 4.13M | 4.1M | 4.07M | 4.03M | 3.9M | 3.74M | 3.69M | 3.66M |
EPS (Basic) | -1.18 | -0.66 | 3.16 | 2.22 | -0.39 | -3.69 | -12.87 | -25.66 | -39.13 | -52.94 | -65.27 | -69.36 | -73.49 | -52.08 | -55.97 | -61.86 | -63.94 | -91.17 | -90.71 | -90.58 | -90.87 | -96.63 |
EPS (Diluted) | -1.18 | -0.67 | 3.12 | 2.18 | -0.43 | -3.72 | -12.87 | -25.66 | -39.13 | -52.94 | -65.27 | -69.36 | -73.49 | -52.08 | -55.97 | -61.86 | -63.94 | -91.19 | -90.73 | -90.60 | -90.89 | -96.63 |
EBITDA | -13.65M | -5.48M | 38.63M | 30.5M | 14.31M | -5.74M | -75.75M | -123.21M | -170.91M | -222.98M | -266M | -276.26M | -291.64M | -203.08M | -217.39M | -239.96M | -239.72M | -341.19M | -330.68M | -318.55M | -308.72M | -303.16M |
EBIT | -13.84M | -5.83M | 36.51M | 27.33M | 9.95M | -11.2M | -80.8M | -128.37M | -176.05M | -227.99M | -270.83M | -281.14M | -296.68M | -208.35M | -223.04M | -246.78M | -247.49M | -349.86M | -340.01M | -327.99M | -318.03M | -312.2M |
Depreciation & Amortization | 186K | 350K | 2.12M | 3.17M | 4.36M | 5.46M | 5.05M | 5.16M | 5.14M | 5.01M | 4.83M | 4.88M | 5.04M | 5.28M | 5.65M | 6.82M | 7.77M | 8.67M | 9.32M | 9.43M | 9.31M | 9.04M |
Add to Watchlist
Select watchlists to add or remove ATRA